pSivida to trade on German exchanges
Thursday, 15 January, 2004
Perth-based nanotech company pSivida (ASX:PSD) will soon commence trading on the German stock exchanges in Berlin, Munich and Stuttgart after meeting all listing requirements, the company has announced.
According to managing director Gavin Rezos, the listings will raise the investment profile of the company in Europe, particularly as pSivida's UK subsidiary pSiMedica prepares to list in the UK.
The listings won't be accompanied by issue of new shares, but instead will allow European institutional and retail investors to trade pSivida shares more easily.
The company has new ties with Germany following its licensing deal with German research agency Forschungszentrum Julich, which has provided pSivida with optical mirror technology for use in its BioSilicon-based in vivo diagnostics project.
pSivida's share price rose nearly eight per cent to AUD$0.69 yesterday on the news.
Quitting smoking increases life expectancy even for seniors
Although the benefits of quitting smoking diminish with age, there are still substantial gains...
Stem cell transplants treat blindness in mini pigs
Scientists have successfully transplanted retinas made from stem cells into blind mini pigs,...
Sugary drinks raise cardiovascular disease risk, but occasional sweets don't
Although higher sugar intake raises your risk of certain cardiovascular diseases, consuming sweet...
